Merck’s Lipfendra is the first FDA-approved pill in the class of cholesterol-lowering drugs called PCSK9 inhibitors. While peptides are typically injected, Lipfendra is a macrocyclic peptide designed for formulation as an oral drug.
The post Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs appeared first on MedCity News.
LG Monitors Silently Install McAfee Adware on Windows PCs With Full System Access
Concerns have arisen regarding LG monitors that reportedly trigger the silent installation of an LG companion application on Windows PCs. This installation is followed by
